EUVIMEDEUVIMED entdecken
CrossrefInfokarte

PRISM: incorporating advanced imaging technologies into a comprehensive strategy for hard-to-heal wound assessment and management

Jeffrey A Niezgoda, Ray Abdo, Brock Liden, Amy Couch, Glyn Jones, Ravi Kamepalli, William Tettelbach

Journal of Wound Care · 2026-11-02 · 35 (11) · 969-980

DOI: 10.12968/jowc.2026.0400 ↗
AbstractBibliografische Angaben

Abstract

Head-to-heal wounds—particularly diabetic lower-extremity wounds—remain among the most challenging and resource-intensive problems in contemporary healthcare, with five-year recurrence rates of 40–65% and a trajectory toward amputation that is frequently driven by three interacting and often under-recognised failures: inadequate perfusion; unrecognised bacterial burden; and unaddressed biomechanical deformity. Near-infrared spectroscopy (NIRS) and bacterial autofluorescence (BAF)—two point-of-care optical imaging technologies—now permit objective, real-time characterisation of the two dominant modifiable barriers to healing: tissue oxygenation and bacterial load. PRISM (perfusion imaging, regional bacterial status, infection staging, structural correction, and maintenance and monitoring) is a structured, imaging-first algorithm that organises these technologies into a single, sequential pathway for hard-to-heal wound assessment and management. This article reviews the operating principles and clinical evidence for NIRS and BAF, expands each of the five PRISM components in a stepwise clinical description, and presents an integrated decision matrix-tree that translates combined imaging findings into actionable, point-of-care interventions. By anchoring every clinical decision in real-time imaging data rather than clinical impression alone, PRISM offers a reproducible framework for earlier identification of healing barriers, more targeted therapy, antimicrobial stewardship, objective longitudinal monitoring and limb preservation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →